Takeda Pharmaceutical (TAK) Receivables - Other: 2018-2025

Historic Receivables - Other for Takeda Pharmaceutical (TAK) over the last 8 years, with Mar 2025 value amounting to $381.1 million.

  • Takeda Pharmaceutical's Receivables - Other rose 0.76% to $380.5 million in Q1 2025 from the same period last year, while for Mar 2025 it was $380.5 million, marking a year-over-year increase of 0.76%. This contributed to the annual value of $381.1 million for FY2025, which is 1.80% down from last year.
  • Per Takeda Pharmaceutical's latest filing, its Receivables - Other stood at $381.1 million for FY2025, which was down 1.80% from $388.1 million recorded in FY2024.
  • In the past 5 years, Takeda Pharmaceutical's Receivables - Other ranged from a high of $713.2 million in FY2021 and a low of $381.1 million during FY2025.
  • Over the past 3 years, Takeda Pharmaceutical's median Receivables - Other value was $388.1 million (recorded in 2024), while the average stood at $439.0 million.
  • Data for Takeda Pharmaceutical's Receivables - Other shows a maximum YoY fell of 29.15% (in 2024) over the last 5 years.
  • Takeda Pharmaceutical's Receivables - Other (Yearly) stood at $713.2 million in 2021, then dropped by 1.18% to $704.8 million in 2022, then declined by 22.28% to $547.8 million in 2023, then declined by 29.15% to $388.1 million in 2024, then dropped by 1.80% to $381.1 million in 2025.